Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Mar 2007 17:05

Plethora Solutions Holdings PLC21 March 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Plethora Solutions Holdings Plc ................. 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : Revised due to DTR rules - see section 13 ( X ) ................. 3. Full name of person(s) subject to the notification obligation (iii): FMRCorp ................. 4. Full name of shareholder(s) (if different from 3.) (iv): shares registered inthe name of Mellon Bank NA for FMR Corp, which is the parent holding company ofFidelity Management & research company (FMRCO) and Fidelity management TrustCompany (FMTC) ................. 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): revised due to DTR rules ................. 6. Date on which issuer notified: 20th March 2007 ................. 7. Threshold(s) that is/are crossed or reached: n/a ................. 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering transaction (vi)using the ISIN CODE Number of shares Number of voting Rights (viii) Ordinary shares (ISIN 431,818 431,818GB00B06GL868) Resulting situation after the triggering transaction (vii) Class/type of shares if Number of shares Number of voting rights (ix) % of voting rightspossible using the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect Ordinary shares (ISIN 431,818 1.65GB00B06GL868) B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rightsfinancial (xiii) Period/ Date (xiv) that may be acquired if theinstrument instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 431,818 1.65 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): N/A Proxy Voting: 10. Name of the proxy holder: FMR Corp ................. 11. Number of voting rights proxy holder will cease to hold: N/A ................. 12. Date on which proxy holder will cease to hold voting rights: N/A ................. 13. Additional information: As discussed with the FSA, prior to theimplementation of the EU transparency directive, we aggregated the interests inshares of FMR Corp (FMR) and Fidelity International Limited (FIL) together forthe purposes of shareholder reporting. According to the new DTR rules we arenow reporting the indirect holdings of FMR and FIL separately. A separationnotification is being submitted for FIL. Please note these holdings are correctas at 16 March 2007 14. Contact name: Brad Hoy 15. Contact telephone number: +44 (0)207 269 8632 ................. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Feb 20077:03 amRNSClinical Update - PSD510
22nd Feb 20077:02 amRNSClinical Update - PSD502
8th Feb 20077:01 amRNSClinical Update
21st Dec 20062:30 pmRNSTotal Voting Rights
5th Dec 20067:03 amRNSProduct Update - ErecAid
27th Nov 20067:01 amRNSProduct Update PSD401
9th Oct 20067:00 amRNSFDA grants label extension
4th Oct 200610:02 amRNSOptions Award
25th Sep 20067:04 amRNSFDA Approval
25th Sep 20067:03 amRNSInterim Results
13th Sep 200611:44 amRNSNotice of Results
22nd Aug 20067:01 amRNSSenior Management Appointment
22nd Aug 20067:01 amRNSClinical Update
10th Aug 20067:00 amRNSSenior Appointment
8th Aug 20067:01 amRNSClinical Update
22nd Jun 20067:02 amRNSIn-Licence and Placing
1st Jun 20067:01 amRNSRe Agreement
27th Apr 20064:11 pmRNSAnnual General Meeting
6th Apr 20064:47 pmRNSShare Options Award
4th Apr 20067:01 amRNSPrelim Results 31 Dec 05
16th Mar 20069:01 amRNSNotice of Results
2nd Mar 20067:00 amRNSFDA Accept Phase II ( PSD597)
21st Feb 20067:01 amRNSLicensing Agreement
13th Feb 20061:27 pmRNSHolding(s) in Company
10th Feb 200611:34 amRNSResult of EGM
6th Feb 200611:25 amRNSResult of EGM
3rd Feb 20065:30 pmRNSHolding(s) in Company
31st Jan 20065:02 pmRNSHolding(s) in Company
13th Jan 20067:30 amRNSProposed Acq and Placing
16th Dec 20057:00 amRNSPSD502 Final Clinical Data
7th Dec 200511:23 amRNSHolding(s) in Company
1st Dec 20057:00 amRNSPSD502 Clinical Trial Data
30th Nov 20052:22 pmRNSHolding(s) in Company
20th Oct 20057:00 amRNSPhase II Clinical Study
26th Sep 20057:03 amRNSInterim Results
26th Sep 20057:00 amRNSProduct Acquisition
12th Sep 20057:00 amRNSPhase II Clinical Trials
31st Aug 20059:38 amRNSNotice of Results
26th Jul 20057:00 amRNSClinical Update
13th Jul 20057:00 amRNSCollaborative Agreement
30th Jun 20058:30 amRNSShare Options Award
22nd Jun 20057:00 amRNSClinical Update
19th May 20057:00 amRNSDirector Dealings
28th Apr 20054:05 pmRNSHolding(s) in Company
18th Apr 20057:00 amRNSRoche Announcement
24th Mar 20058:00 amRNSFirst Day Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.